Mode
Text Size
Log in / Sign up

PRP shows limited structural benefit in knee osteoarthritis, with patellofemoral cartilage and bone marrow edema signalsPlatelet-rich plasma shows mixed results for knee osteoarthritis structure

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret PRP's structural benefits in knee osteoarthritis cautiously; evidence is limited and inconsistent.

This meta-analysis pooled data from 1200 patients with knee osteoarthritis to evaluate the association between platelet-rich plasma (PRP) and imaging-based structural outcomes compared with control treatments. The analysis examined several structural endpoints, including cartilage thickness/volume at the patellofemoral and medial tibial compartments, cartilage defect progression, Whole-Organ Magnetic Resonance Imaging Score (WORMS) osteophytes, subchondral cysts, bone marrow edema, and synovitis.

PRP was associated with greater improvement in patellofemoral cartilage thickness/volume (SMD 0.94; 95% CI, 0.53 to 1.34) and a significant reduction in bone marrow edema (SMD -0.40; 95% CI, -0.71 to -0.09) compared with control treatments. No significant between-group differences were found for medial tibial cartilage thickness/volume, cartilage defect progression, WORMS osteophytes, subchondral cysts, or synovitis (SMD -0.22; 95% CI, -0.43 to 0.00).

The authors note that the findings for patellofemoral cartilage and bone marrow edema should be interpreted with caution, and that the overall evidence shows limited and inconsistent effects on imaging-based structural outcomes. Adverse events, follow-up duration, and funding sources were not reported.

In practice, these results do not provide clear evidence supporting PRP as a structural disease-modifying treatment for knee osteoarthritis. The observed signals in patellofemoral cartilage and bone marrow edema require cautious interpretation given the limitations noted by the authors.

How this fits prior evidence

This meta-analysis extends prior coverage of knee osteoarthritis by examining structural imaging outcomes with PRP, whereas previous items focused on symptom and function interventions such as patient education plus exercise (pain reduction by MD -3.28), digitally supported exercise (improved physical function), and moderate-intensity isotonic exercise (function improvement by MD -16.66). It also contrasts with the surgical focus of cementless mobile-bearing unicompartmental knee arthroplasty (noninferior survivorship) and with research trends toward metabolic and inflammatory signaling. The limited and inconsistent structural effects reported here do not confirm a disease-modifying role for PRP, and the authors' caution aligns with the need for conservative interpretation.

Living with knee osteoarthritis can feel like a constant battle against wear and tear. Patients often look for treatments that do more than just mask pain, aiming instead to protect the physical structure of the joint. A large review of 1,200 patients looked at whether platelet-rich plasma (PRP) could actually change the physical makeup of the knee.

The data showed some specific improvements. Patients receiving PRP saw better patellofemoral cartilage thickness and a significant reduction in bone marrow edema, which is swelling inside the bone. However, the treatment did not show significant differences in other areas, such as medial tibial cartilage, cartilage defect progression, or the size of bone spurs.

Because the results were inconsistent across different types of tissue, experts suggest being cautious. While some specific areas showed improvement, the findings do not provide clear evidence that PRP works as a disease-modifying treatment that stops the overall progression of the condition. Talk to your doctor to see how these specific findings might fit into your personal care plan.

What this means for you:
Platelet-rich plasma shows some specific structural improvements but is not proven to slow overall disease progression.

Common questions

Does platelet-rich plasma (PRP) improve knee cartilage?

The study found that platelet-rich plasma led to greater improvement in patellofemoral cartilage thickness compared to control treatments. However, it did not show significant differences in other areas, such as medial tibial cartilage or the progression of cartilage defects.

Can PRP treat the underlying causes of knee osteoarthritis?

While the treatment showed a significant reduction in bone marrow edema, the overall findings do not provide clear evidence that platelet-rich plasma works as a structural disease-modifying treatment. This means it may not stop the overall progression of the disease.

What are the limitations of these findings?

The results for patellofemoral cartilage and bone marrow edema should be interpreted with caution. The study noted that there were limited and inconsistent effects on many of the imaging-based structural outcomes for knee osteoarthritis.

Study Details

Study typeMeta analysis
Sample sizen = 1,200
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
PURPOSE: To assess the impact of platelet-rich plasma (PRP) on imaging-based structural outcomes in patients with knee osteoarthritis (OA). METHODS: PubMed, Embase, and the Cochrane Library were systematically searched for randomized controlled trials (RCTs) published up to May 2026 evaluating imaging-based structural effects of PRP in knee OA. Risk ratio (RR) was used to evaluate binary outcomes and standardized mean differences (SMDs) or mean differences (MDs) for continuous endpoints, with 95% confidence intervals (CIs). RESULTS: A total of 12 RCTs involving 1,200 patients were included. PRP was associated with greater improvement in patellofemoral cartilage thickness/volume compared with control treatments (SMD 0.94; 95% CI, 0.53 to 1.34), whereas no significant differences were observed for medial tibial cartilage thickness/volume or cartilage defect progression. Magnetic resonance imaging (MRI)-based structural scores showed no between-group differences in Whole-Organ Magnetic Resonance Imaging Score (WORMS) osteophytes or subchondral cysts, although PRP demonstrated a significant reduction in bone marrow edema (SMD - 0.40; 95% CI, - 0.71 to - 0.09). Synovitis did not differ overall between groups (SMD - 0.22; 95% CI, - 0.43 to 0.00). CONCLUSION: In this systematic review and meta-analysis, PRP demonstrated limited and inconsistent effects on imaging-based structural outcomes in knee OA, and did not confer significant and consistent benefits in medial tibial cartilage measurements, cartilage defect progression, synovitis, or most WORMS domains. The favorable findings observed for patellofemoral cartilage and bone marrow edema should be interpreted with caution. Thus, the findings do not provide clear evidence supporting PRP as a structural disease-modifying treatment, and additional high-quality RCTs using standardized imaging endpoints are warranted.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.